BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36511871)

  • 1. Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients.
    Cho S; Vigers T; Pyle L; Franklin A; Sopfe J; Jeney F; Forlenza G
    Diabetes Technol Ther; 2023 Feb; 25(2):116-121. PubMed ID: 36511871
    [No Abstract]   [Full Text] [Related]  

  • 2. Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients.
    Sopfe J; Pyle L; Keating AK; Campbell K; Liu AK; Wadwa RP; Verneris MR; Giller RH; Forlenza GP
    Blood Adv; 2019 Feb; 3(3):350-359. PubMed ID: 30718242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Accuracy of Factory-Calibrated Continuous Glucose Monitoring in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation.
    Sopfe J; Vigers T; Pyle L; Giller RH; Forlenza GP
    Diabetes Technol Ther; 2020 Oct; 22(10):727-733. PubMed ID: 32105513
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycemic variability is associated with poor outcomes in pediatric hematopoietic stem cell transplant patients.
    Sopfe J; Campbell K; Keating AK; Pyle L; Liu AK; Verneris MR; Giller RH; Forlenza GP
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28626. PubMed ID: 33480469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study.
    Bhatt NS; Sharma A; St Martin A; Abid MB; Brown VI; Diaz Perez MA; Frangoul H; Gadalla SM; Herr MM; Krem MM; Lazarus HM; Martens MJ; Mehta PA; Nishihori T; Prestidge T; Pulsipher MA; Rangarajan HG; Williams KM; Winestone LE; Yin DE; Riches ML; Dandoy CE; Auletta JJ
    Transplant Cell Ther; 2022 Oct; 28(10):696.e1-696.e7. PubMed ID: 35798233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of intraoperative continuous glucose monitoring: An observational study in general surgery patients.
    Price CE; Fanelli JE; Aloi JA; Anzola SC; Vishneski SR; Saha AK; Woody CC; Segal S
    J Clin Anesth; 2023 Aug; 87():111090. PubMed ID: 36913777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients.
    Seo E; Choi ES; Kim JH; Kim H; Koh KN; Im HJ; Lee J
    PLoS One; 2021; 16(2):e0246191. PubMed ID: 33544726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of aging and frailty on inpatient glycemic control by continuous glucose monitoring in patients with type 2 diabetes.
    Idrees T; Zabala ZE; Moreno EM; Gerges A; Urrutia MA; Ruiz JG; Vaughan C; Vellanki P; Pasquel FJ; Peng L; Umpierrez GE
    Diabetes Res Clin Pract; 2023 Apr; 198():110603. PubMed ID: 36871877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of Inpatient CGM: Comparison to Standard of Care.
    Price C; Ditton G; Russell GB; Aloi J
    J Diabetes Sci Technol; 2023 Mar; 17(2):329-335. PubMed ID: 34911384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic Stem Cell Transplantation in Children and Young Adults.
    Galletta TJ; Lane A; Lutzko C; Leemhuis T; Cancelas JA; Khoury R; Wang YM; Hanley PJ; Keller MD; Bollard CM; Davies SM; Grimley MS; Rubinstein JD
    Transplant Cell Ther; 2023 May; 29(5):305-310. PubMed ID: 36736781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies.
    Augstein P; Heinke P; Vogt L; Vogt R; Rackow C; Kohnert KD; Salzsieder E
    BMC Endocr Disord; 2015 May; 15():22. PubMed ID: 25929322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
    Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
    Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluid balance of pediatric hematopoietic stem cell transplant recipients and intensive care unit admission.
    Benoit G; Phan V; Duval M; Champagne M; Litalien C; Merouani A
    Pediatr Nephrol; 2007 Mar; 22(3):441-7. PubMed ID: 17123119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic improvement with a novel interim intervention technique using retrospective professional continuous glucose monitoring (GLITTER study): A study from Mumbai, India.
    Jain AB
    Diabetes Metab Syndr; 2021; 15(3):703-709. PubMed ID: 33813245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.
    Hammer MJ; Casper C; Gooley TA; O'Donnell PV; Boeckh M; Hirsch IB
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):344-51. PubMed ID: 19203725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.
    Haynes AS; Curtis DJ; Campbell K; Giller RH; Quinones RR; Verneris MR; Abzug MJ
    Transplant Cell Ther; 2021 Apr; 27(4):317-326. PubMed ID: 33836875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.